Medical Health & Life Science Research News

United States, Mexico & Canada: kidney transplant market forecasts to 2020 illuminated by new report

The improvement in technology, surgical techniques and immunosuppressive drugs, Kidney transplantation has became the preferred treatment for chronic kidney disease for many people. A transplant may offer the best chance of returning to a more normal life.

 

Kidney transplantation has increasingly become a pivotal intervention for thousands of patients suffering from fatal end stage kidney disease (ESRD).

Complete report available at www.marketreportsonline.com/400060.html.

- Advertising -

- Agency -

North America is one of the biggest kidney transplant market in the world. The overall number of Kidney Transplant done in North America (United States, Mexico and Canada) was more than 20 Thousand in 2014.

United States is the leader in kidney transplant market in North America. Canada has the least number of kidney transplant done in comparison to United States and Mexico.

Despite its high medical cost today United States Kidney Transplant Market is a Billion US$ industry.

This research study titled “Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada” explores a comprehensive assessment of the fast–evolving, high growth Kidney Transplant Market. This 53 page report with 33 Figures & 1 Table provides the number of kidney transplant, as well as market and market shares of Kidney Transplant Market.

The report entails major kidney transplant (Immunosuppressant) drug sales analysis. This report also covers drivers and challenges of North America (United States, Mexico and Canada) market.

All the 3 Countries studied in the report are as follows

  • United States
  • Canada
  • Mexico

All the 6 Kidney Transplant Immunosuppressant) drugs studied in the report are as follows

  • CellCept (MycophenolateMofetil)
  • Prograf (Tacrolimus)
  • Rapamune (Sirolimus)
  • Myfortic (Mycophenolic Acid)
  • Neoral / Sandimmune (Cyclosporine)
  • Zortress / Certican (Everolimus)

Report at www.marketreportsonline.com/contacts/400060.

Table of Contents

1. Executive Summary

2. North America (United States, Mexico & Canada) – Number of Kidney Transplant & Forecast

3. North America (United States, Mexico & Canada) – Kidney Transplant Market & Forecast

4. North America (United States, Mexico & Canada) – Number of Kidney Transplant, Market & Drugs Market Share & Forecast
4.1 North America (United States, Mexico & Canada) – Number of Kidney Transplant Share & Forecast
4.2 North America (United States, Mexico & Canada) – Kidney Transplant Market Share & Forecast
4.3 Number of Kidney Transplant Centers in United States, Canada & Mexico

5. United States
5.1 United States – Number of Kidney Transplant & Forecast
5.2 United States – Kidney Transplant Market & Forecast

6. Mexico
6.1 Mexico – Number of Kidney Transplant & Forecast
6.2 Mexico – Kidney Transplant Market & Forecast

7. Canada
7.1 Canada – Number of Kidney Transplant & Forecast
7.2 Canada – Kidney Transplant Market & Forecast

8. Kidney Transplantation (Immunosuppressant) Drug Sales Analysis
8.1 CellCept (MycophenolateMofetil) Drugs Sales & Forecast
8.2 Prograf (Tacrolimus) Drug Sales & Forecast
8.3 Rapamune (Sirolimus) Drug Sales & Forecast
8.4 Myfortic (Mycophenolic Acid) Drug Sales & Forecast
8.5 Neoral / Sandimmune (Cyclosporine) Drug Sales & Forecast
8.6 Zortress / Certican (Everolimus) Drug Sales & Forecast

9. Growth Drivers in the Kidney Transplant Market
9.1 Frequency of Living Related Kidney Donation Has Increased
9.2 Patients Who Have Kidney Transplants Usually Live Longer Than Patients Receiving Dialysis

10. Challenges in the Kidney Transplant Market
10.1 Kidney Transplant Waitlist is Long

 

...